Changes of Red Blood Cell Surface Markers in a Blood Doping Model of Neocytolysis

作者: Chung-Che Chang , Yayan Chen , Kapil Modi , Omar G. Awar , Clarence P. Alfrey

DOI: 10.2310/JIM.0B013E3181A3914E

关键词:

摘要: Background: Neocytolysis, the selective hemolysis of young circulating red blood cells (RBCs), contributes to physiologic control cell mass and pathophysiologic phenomena such as anemia renal disease, after spaceflight, doping by athletes. Progress in understanding process is hampered lack established markers distinguish from older RBC. Methods: Twelve potentially informative RBC surface were assayed flow cytometry normal samples, 4 preferentially expressed To create a model neocytolysis, 3 volunteers had recombinant human erythropoietin (rhEpo) administered until mild erythrocytosis occurred, then studied upon rhEpo withdrawal. Results: Neocytolysis ensued that most evident rapid rise serum ferritin iron was transferred back stores. Five additional monitored during administration. Three subjects with marginal baseline stores blunted response rhEpo, no significant change marker expression. Two adequate developed followed neocytolysis. Decreased expression CD44 (homing-associated adhesion molecule) CD71 (transferrin receptor) seemed correlate best neocytolysis; CD35 (complement less so. Of note, further studies are needed determine if these changes causative destruction. Conclusion: This study begins establish differentiating old RBC, basis for better definition process. Although our preliminary, results support possibility could be useful detect because neocytolysis should predictably occur athletes who surreptitiously dope.

参考文章(26)
Domenico Ribatti, Marco Presta, Angelo Vacca, Roberto Ria, Roberta Giuliani, Patrizia Dell’Era, Beatrice Nico, Luisa Roncali, Franco Dammacco, Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo Blood. ,vol. 93, pp. 2627- 2636 ,(1999) , 10.1182/BLOOD.V93.8.2627
Jutta Marfurt, Jürg A. Schifferli, Salima Sadallah, Estelle Lach-Trifilieff, Sybille Schwarz, Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. Journal of Immunology. ,vol. 162, pp. 7549- 7554 ,(1999)
Joseph M. Ahearn, Douglas T. Fearon, Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Advances in Immunology. ,vol. 46, pp. 183- 219 ,(1989) , 10.1016/S0065-2776(08)60654-9
BE Gee, OS Platt, Sickle Reticulocytes Adhere to VCAM-1 Blood. ,vol. 85, pp. 268- 274 ,(1995) , 10.1182/BLOOD.V85.1.268.BLOODJOURNAL851268
C. P. Alfrey, M. M. Udden, C. Leach-Huntoon, T. Driscoll, M. H. Pickett, Control of red blood cell mass in spaceflight Journal of Applied Physiology. ,vol. 81, pp. 98- 104 ,(1996) , 10.1152/JAPPL.1996.81.1.98
Bernard A. Harris, Paul E. Epstein, Out of thin air: the evolving enigma of erythropoietin and neocytolysis. Annals of Internal Medicine. ,vol. 134, pp. 710- 712 ,(2001) , 10.7326/0003-4819-134-8-200104170-00015
George L Dale, Shannon L Norenberg, None, Density fractionation of erythrocytes by Percoll/hypaque results in only a slight enrichment for aged cells. Biochimica et Biophysica Acta. ,vol. 1036, pp. 183- 187 ,(1990) , 10.1016/0304-4165(90)90032-R
JY Yiannakou, P Newland, F Calder, AN Kingsnorth, Jonathan M Rhodes, Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer. The Lancet. ,vol. 349, pp. 389- 392 ,(1997) , 10.1016/S0140-6736(97)80011-6
Ramesh K. Wali, Stuart Jaffe, Dinesh Kumar, Nino Sorgente, Vijay K. Kalra, Increased adherence of oxidant-treated human and bovine erythrocytes to cultured endothelial cells. Journal of Cellular Physiology. ,vol. 133, pp. 25- 36 ,(1987) , 10.1002/JCP.1041330104